| 000 | 018030000a22003370004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223025807.0 | ||
| 008 | 060917s2006 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.09.M.Sc.2006.Ra.A | ||
| 100 | 0 | _aRania Khalaf Abdelhamid Abdelkader | |
| 245 | 1 | 0 |
_aAssessment of hepatic metabolic function in patients with chronic liver disease / _cRania Khalaf Abdelhamid Abdelkader ; Supervised Samira Saleh Mostafa , Sanaa Sabet Botros |
| 246 | 1 | 5 | _aتعيين لوظيفة الايض الكبدى فى المرضى المصابين بامراض الكبد المزمنة |
| 260 |
_aCairo : _bRania Khalaf Abd El Hamid Abd El Kader , _c2006 |
||
| 300 |
_a101 P. : _bcharts ; _c30cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology | ||
| 520 | _aChronic hepatitis C (HCV) is a major health problem in EgyptAntipyrine clearance (APC) is a quantitative measure of hepatic metabolic functionDimethyl diphenyl bicarboxylate (DDB) is one of the alternative medicines for hepatitisIt was found to improve the abnormal serum aminotransferases in HCV patientsConventional liver function tests in comparison to APC were used to investigate the effect of DDB in HCV patientsPatients divided according to Child - Pugh classification | ||
| 530 | _aIssued Also as CD | ||
| 653 | 4 | _aAntipyrine clearance | |
| 653 | 4 | _aChronic hepatitis C | |
| 653 | 4 | _aDimethyl diphenyl bicarboxylate | |
| 700 | 0 |
_aSamira Saleh Mostafa , _eSupervisor |
|
| 700 | 0 |
_aSanaa Sabet Botros , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c20779 _d20779 |
||